Related Experiment Video
Updated: Jul 24, 2026
07:25
Driving Under the Influence: How Music Listening Affects Driving Behaviors
Published on: March 27, 2019
[Drowsiness--greater traffic hazard than alcohol. Causes, risks and treatment]
1Institutionen för öron-, näs- och halssjukdomar, Karolinska institutet. per-olle.haraldsson@ks.se
Lakartidningen
|July 21, 2001
Summary
Drowsy driving, a significant risk factor in traffic accidents, is often caused by sleep disorders like obstructive sleep apnea syndrome (OSAS). Effective treatments can restore safe driving capabilities.
Area of Science:
- Sleep Medicine
- Traffic Safety
- Neurology
Context:
- Drowsy driving is an underestimated cause of traffic accidents, potentially responsible for 15-30% of collisions.
- It poses a greater risk than alcohol, leading to inattention, impaired concentration, and fatal accidents.
- Habitual drowsiness stems from various conditions including sleep apnea, insomnia, and shift work.
Purpose:
- To highlight the prevalence and dangers of drowsy driving.
- To identify obstructive sleep apnea syndrome (OSAS) as a primary cause of habitual drowsiness in drivers.
- To discuss the effectiveness of treatments and the implications for driving safety.
Summary:
- Obstructive sleep apnea syndrome (OSAS) is the most common cause of habitual drowsy driving in middle-aged men, increasing accident risk by 2-3 times.
- Treatments like palatoplasty and nasal CPAP significantly improve vigilance and driving performance, mitigating accident risks.
- Drivers experiencing drowsiness or micro-sleep require medical attention; untreated cases may necessitate reporting to authorities to ensure public safety.
Impact:
- Raises awareness about the critical role of sleep health in road safety.
- Emphasizes the need for medical evaluation and treatment for habitual drowsiness in drivers.
- Informs policy and public health initiatives aimed at reducing traffic accidents caused by sleep-related impairment.
Related Concept Videos
01:27CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
01:14CNS Depressants: Barbiturates and Benzodiazepines
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
01:20Sedatives and Hypnotics Drugs: Barbiturates
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A key...
01:19Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:28Depressants
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...